Biochemistry, Genetics and Molecular Biology
Agonist
50%
Cell Activity
12%
Cell Function
50%
Cell Growth
50%
Clinical Trial
12%
Cytotoxicity
8%
down Regulation
12%
Enteroendocrine Cell
50%
Gastric Inhibitory Polypeptide
8%
Gene Expression
8%
Glucagon-Like Peptide-1
8%
Glucose Homeostasis
50%
Hormone Release
8%
Incretin
20%
Insulin Blood Level
8%
Insulin Release
8%
Messenger RNA
12%
Microribonucleic Acid
50%
MicroRNA
50%
Neuropeptide
50%
Non-Coding RNA
25%
Ob/Ob Mouse
8%
Oxytocin
50%
Peptidase
7%
Peptide YY
50%
Protein Biosynthesis
12%
Real-Time Polymerase Chain Reaction
8%
RNA Sequence
12%
Satiety
8%
Secretion (Process)
20%
Upregulation
20%
Western Blotting
8%
Immunology and Microbiology
Agonist
100%
Antidiabetic Activity
50%
Body Weight
25%
Cell Function
75%
Cell Proliferation
25%
Cholesterol Blood Level
25%
Cytotoxicity
8%
Enteroendocrine Cell
50%
Fat Mass
25%
Gene Expression
8%
Glucose Blood Level
50%
Glucose Homeostasis
50%
Hormone Release
8%
Insulin Blood Level
8%
Insulin Release
8%
Insulin Sensitivity
50%
Ob/Ob Mouse
33%
Real-Time Polymerase Chain Reaction
8%
Satiety
8%
Secretion (Process)
8%
Upregulation
8%
Western Blot
8%
Pharmacology, Toxicology and Pharmaceutical Science
AM251
25%
Antidiabetic Agent
8%
Calcium Ion
8%
Clinical Trial
10%
Combination Therapy
8%
Dipeptidyl Peptidase IV Inhibitor
8%
Disease
10%
Disease Exacerbation
10%
Endocannabinoid
16%
G Protein Coupled Receptor
50%
Gastric Inhibitory Polypeptide
50%
Glucagon
10%
Glucagon-Like Peptide-1
16%
Incretin
43%
Messenger RNA
18%
microRNA
50%
Monotherapy
16%
Non Insulin Dependent Diabetes Mellitus
58%
Peptidase
7%
Peptide YY
50%
Receptor
8%
Sitagliptin
8%
Tuck Ordinary Mouse
8%
Untranslated RNA
20%
